7
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Fibromyalgia

2. Management guidelines and research findings

, MD, MS(Med) & , PhD
Pages 57-69 | Published online: 16 May 2016

References

  • Moldofsky H, Scarisbrick P, England R, et al. Musculoskeletal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom Med 1975: 37(4): 341–51
  • Moldofsky H, Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1976: 38(1): 35–44
  • Moldofsky H, Lue F, Smythe H. Alpha-EEG sleep and pain In rheumatoid arthritis. Sleep Res 1979: 8: 236
  • Moldofsky H. Rheumatic pain modulation disorder: the interrelationships between sleep. CNS serotonin and pain. In: Critchley M. Friedman A. Gorini S, et al. eds. Headache: physiopathological and clinical concepts. Vol 1. New York: Raven Press, 1982: 51–7 (Advances in neurology series, vol 33)
  • Moldofsky H, Lue F. The relationship of alpha and delta EEG frequencies to pain and mood in “fibrositis” patients treated with chlorpromazine and L-tryptophan. EEG Clin Neurophysiol 1980: 50: 71–80
  • Moldofsky H, Lue FA, Saskin P. Sleep and morning pain in primary osteoarthritis. Sleep Res 1985: 15: 198
  • Moldofsky H, Lue FA, Saskin P, et al. Sleep and symptoms in psychophysiologic persistent insomnia versus rheumatic pain modulation disorder (fibrositis syndrome). Sleep Res 1986: 15: 199
  • Saskin P, Moldofsky H, Lue FA. Sleep and posttraumatic rheumatic pain modulation disorder (fibrositis syndrome). Psychosom Med 1986: 48(5): 319–23
  • Van Woert MH, Sethy VH. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK486. Neurology (Minneapolis) 1975: 25(2): 135–40
  • Sicuteri F. Headache as a possible expression of deficiency of brain 5-hydroxytryptamine (central denervation sensitivity). Headache 1972: 12(Jul): 69–72
  • Harvey JA, Lints CE. Lesions In the medial forebrain bundle: delayed effects on sensitivity to electric shock. Science 1965: 148(Apr): 250–2
  • Harvey JA, Schlosberg AJ, Yunger LM. Behavioral correlates of serotonin depletion. Fed Proc 1975: 34(9): 1796–801
  • Messing RB, Fisher LA, Phebus L, et al. Interaction of diet and drugs in the regulation of brain 5-hydroxyindoles and the response to painful electric shock. Life Sci 1976: 18(7): 704–14
  • Samanin R. Gumulka W, Valzelli L. Reduced effect of morphine in midbrain raphe lesioned rats. Eur J Pharmacol 1970: 10(3): 339–43
  • Tenen SS. The effects of p-chlorophenylalanine, a serotonin depletor, on avoidance acquisition, pain sensitivity and related behavior in the rat. Psychopharmacologia 1967: 10(3): 204–19
  • Buchel L. Levy J, Tanguy O. Sur la potentialization de l'action analgesique de la 1-methadon par la 5-hydroxytryptamine (serotonine). CR Acad Sci (Paris) 1958: 246: 2947–9
  • Riley GJ, Shaw DM. Total and non-bound tryptophan in unipolar illness. (Letter) Lancet 1976: 2(7997): 1249
  • Samanin R, Valzelli L. Serotoninergic neurotransmission and morphine activity. Arch Int Pharmacodyn Ther 1972: 196(Suppl 196): 138–44
  • Dewey WL, Harris LS, Howes JF, et al. The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J Pharmacol Exp Ther 1970: 175(2): 435–42
  • Major CT, Pleuvry BJ. Effects of alpha-methyl-p-tyrosine, p-chlorophenylalanine, 1-beta- (3.4-dihydroxyphenyl)alanlne, 5-hydroxytryptophan and diethyldithiocarbamate on the analgesic activity of morphine and methylamphetamine in the mouse. Br J Pharmacol 1971: 42(Aug): 512–21
  • Tenen SS. Antagonism of the analgesic effect of morphine and other drugs by p-chlorophenylalanine, a serotonin depletor. Psychopharmacologia 1968: 12(4): 278–85
  • Knott PJ, Curzon G. Free tryptophan in plasma and brain tryptophan metabolism. Nature 1972: 239(373): 452–3
  • Tagliamonte A, Tagliamonte P, Perez-Cruet J, et al. Increase of brain tryptophan caused by drugs which stimulate serotonin synthesis. Nature (New Biol) 1971: 229(4): 125–6
  • Moldofsky H, Warsh J J. Plasma tryptophan and musculoskeletal pain in non-articular rheumatism (“fibrositis syndrome”). Pain 1978: 5(1): 65–71
  • Masi AT, Yunus MB. The primary fibromyalgia syndrome (PFS): fact or fancy? In: Postgraduate advances in rheumatology course (Forum medicus series). Princeton. NJ: Nassau Press, 1986
  • Caro XJ. Immunofluorescent detection of IgG at the dermal-epidermal Junction In patients with apparent primary fibrositis syndrome. Arthritis Rheum 1984: 27(10): 1174–9
  • Caro XJ, Quismorio FP Jr. IgG subclass distribution of deposits at the dermal-epidermal Junction of skin in primary fibrositis syndrome. Arthritis Rheum 1986: 29: D32
  • Dinerman H, Felson DT, Goldenberg DL, et al. Lupus band test with antinuclear antibodies in fibromyalgia. Arthritis Rheum 1985: 28: S53
  • Kaplan H, Brooke MH. Histochemical study of muscle in rheumatic disease. Arthritis Rheum 1971: 14: 168–9
  • Yunus M. Masi AT, Calabro JJ, et al. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981: 11(1): 151–71
  • Fricton JR, Auvinen MD, Dykstra D, et al. Myofascial pain syndrome: electromyographic changes associated with local twitch response. Arch Phys Med Rehabil 1985: 66(5): 314–7
  • Bartels EM, Danneskiold-Samsøe B. Histological abnormalities in muscle from patients with certain types of fibrositis. Lancet 1986: 1(8484): 755–7
  • Wolfe F, Cathey MA, Kleinheksel SM. Fibrositis (fibromyalgia) in rheumatoid arthritis. J Rheumatol 1984: 11(6): 814–8
  • Leavitt F, Katz RS, Golden HE, et al. Comparison of pain properties in fibromyalgia patients and rheumatoid arthritis patients. Arthritis Rheum 1986: 29(6): 775–81
  • Weinberger LM. Traumatic fibromyositis: a critical review of an enigmatic concept. West J Med 1977: 127(2): 99–103
  • Clark S, Campbell SM, Forehand ME, et al. Clinical characteristics of fibrositis. II. A “blinded,” controlled study using psychological tests. Arthritis Rheum 1985: 28(2): 132–7
  • Payne TC, Leavitt F, Garron DC, et al. Fibrositis and psychologic disturbance Arthritis Rheum 1982: 25(2): 213–7
  • Moldofsky H. Chester WJ. Pain and mood patterns in patients with rheumatoid arthritis: a prospective study. Psychosom Med 1970: 32(3): 309–18
  • McDaniel LK, Anderson KO, Bradley LA, et al. Development of an observation method for assessing pain behavior in rheumatoid arthritis patients. Pain 1986: 24(2): 165–84
  • Hudson JI, Hudson MS, Pliner LF, et al. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 1980: 142(4): 441–6
  • Campbell SM. Clark S, Tindall E A, et al. Clinical characteristics of fibrositis. I. A “blinded,” controlled study of symptoms and tender points. Arthritis Rheum 1986: 26(7): 817–24
  • Bradley LA, Anderson KO, Young LD, et al. Is psychological disturbance highly associated with primary fibrositis? Evidence that primary fibrositis is not a form of psychogenic rheumatism. New Dir Behav Med Res 1985: 6(4): 145–7
  • Ahles TA, Yunus MB, Riley SD, et al. Psychological factors associated with primary fibromyalgia syndrome. Arthritis Rheum 1984: 27(10): 1101–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.